Skip to Content
Merck
CN

SML3056

Bevantolol Hydrochloride

≥98% (HPLC)

Synonym(s):

NC 1400, Ranestol, 1-[(3,4-Dimethoxyphenethyl)amino]-3-(m-tolyloxy)-2-propanol hydrochloride, 2-Propanol,1-[[2-(3,4-dimethoxyphenyl)ethyl]amino]-3-(3-methylphenoxy)-, hydrochloride (1:1), CI 775, Cl 775, Sentiloc, Vantol

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Empirical Formula (Hill Notation):
C20H27NO4 · HCl
CAS Number:
Molecular Weight:
381.89
UNSPSC Code:
12352200
NACRES:
NA.77
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Bevantolol Hydrochloride, ≥98% (HPLC)

InChI

1S/C20H27NO4.ClH/c1-15-5-4-6-18(11-15)25-14-17(22)13-21-10-9-16-7-8-19(23-2)20(12-16)24-3;/h4-8,11-12,17,21-22H,9-10,13-14H2,1-3H3;1H

SMILES string

OC(COC1=CC=CC(C)=C1)CNCCC2=CC(OC)=C(C=C2)OC.Cl

InChI key

FJTKCFSPYUMXJB-UHFFFAOYSA-N

assay

≥98% (HPLC)

form

powder

storage condition

desiccated

color

white to beige

solubility

H2O: 2 mg/mL, clear

storage temp.

2-8°C

Quality Level

Biochem/physiol Actions

Bevantolol is orally available, anti-hypertension agent that acted as both a beta blocker and a calcium channel blocker. Bevantolol is a beta 1 (β1) adrenoceptor antagonist with alpha1 (α1)-adrenoceptor partial antagonist activity. Bevantolol had no effect on the beta-adrenoceptor density and their subtype proportions after chronic administration in rats.
orally available, anti-hypertension agent that acted as both a beta blocker and a calcium channel blocker; β1- and α1- adrenoceptor antagonist

pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Acute Tox. 4 Oral

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Takahiro Horinouchi et al.
Life sciences, 81(5), 399-404 (2007-07-14)
Recently, tissue segment binding method with a hydrophilic radioligand [(3)H]-CGP12177 was developed to detect plasma membrane beta-adrenoceptors in rat heart (Horinouchi et al., 2006). In the present study, propranolol (40 mg kg(-1) day(-1)), atenolol (40 mg kg(-1) day(-1)) and bevantolol
Gavin W K Wong et al.
The Cochrane database of systematic reviews, 3, CD007451-CD007451 (2016-03-11)
Beta blockers are commonly used to treat hypertension. The blood pressure reading is the primary tool for physicians and patients to assess the efficacy of the treatment. The blood pressure lowering effect of beta-1 selective blockers is not known. To
David J Augeri et al.
Journal of medicinal chemistry, 48(15), 5025-5037 (2005-07-22)
Efforts to further elucidate structure-activity relationships (SAR) within our previously disclosed series of beta-quaternary amino acid linked l-cis-4,5-methanoprolinenitrile dipeptidyl peptidase IV (DPP-IV) inhibitors led to the investigation of vinyl substitution at the beta-position of alpha-cycloalkyl-substituted glycines. Despite poor systemic exposure
Barbara Malinowska et al.
British journal of pharmacology, 139(8), 1548-1554 (2003-08-19)
1. Atypical beta-adrenoceptors resistant to propranolol, but blocked by bupranolol, increase contractile force and/or frequency of the heart in humans and rats. We compared the potencies of the enantiomers of bupranolol and examined the possible effects of seven bupranolol analogues

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service